5401 - 5425 of 9035 Results
Title
Year
-
OPENTitle: Resting‐State Functional Connectivity in Frontostriatal and Posterior Cortical Subtypes in Parkinson's Disease‐Mild Cognitive ImpairmentJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 502End Page: 512Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28888Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28888Citation Count: 39
-
OPENTitle: Dairy Intake and Parkinson's Disease: A Mendelian Randomization StudyJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 857End Page: 864Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28902Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28902Citation Count: 45
- Validation of the Arabic Version of the Movement Disorder Society‐Unified Parkinson's Disease Rating Scale2022RESTRICTEDTitle: Validation of the Arabic Version of the Movement Disorder Society‐Unified Parkinson's Disease Rating ScaleJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 826End Page: 841Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28905Citation Count: 8
- What's New at the Journal in 20222022RESTRICTEDTitle: What's New at the Journal in 2022Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 1End Page: 2Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28906Citation Count: 0
- Unmet Needs of Women Living with Parkinson's Disease: Gaps and Controversies2022RESTRICTEDTitle: Unmet Needs of Women Living with Parkinson's Disease: Gaps and ControversiesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 444End Page: 455Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28921Citation Count: 101
- c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and Opportunities2022RESTRICTEDTitle: c‐Abl Inhibitors as Disease‐Modifying Therapies for Parkinson's Disease: Gaps and OpportunitiesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 1Start Page: 3End Page: 5Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28907Citation Count: 3
- Combining Skin α‐Synuclein Real‐Time Quaking‐Induced Conversion and Circulating Neurofilament Light Chain to Distinguish Multiple System Atrophy and Parkinson's Disease2022RESTRICTEDTitle: Combining Skin α‐Synuclein Real‐Time Quaking‐Induced Conversion and Circulating Neurofilament Light Chain to Distinguish Multiple System Atrophy and Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 648End Page: 650Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28912Citation Count: 36
- Down‐Regulation of Dopamine Transporter in Early Premotor Phases2022RESTRICTEDTitle: Down‐Regulation of Dopamine Transporter in Early Premotor PhasesJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 663End Page: 664Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28924Citation Count: 0
- Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson Disease2022RESTRICTEDTitle: Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 654End Page: 654Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28936Citation Count: 2
- Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or Severity2022RESTRICTEDTitle: Glucocerebrosidase Activity Is Not Associated with Parkinson's Disease Risk or SeverityJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 3Start Page: 651End Page: 652Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28929Citation Count: 7
-
OPENTitle: The Contribution of Subthalamic Nucleus Deep Brain Stimulation to the Improvement in Motor Functions and Quality of LifeJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 2Start Page: 291End Page: 301Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28952Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28952Citation Count: 23
- The Neuroinflammatory Acute Phase Response in Parkinsonian‐Related Disorders2022RESTRICTEDTitle: The Neuroinflammatory Acute Phase Response in Parkinsonian‐Related DisordersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 993End Page: 1003Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28958Citation Count: 14
- Lateralized Subthalamic Stimulation for Axial Dysfunction in Parkinson's Disease: A Randomized Trial2022RESTRICTEDTitle: Lateralized Subthalamic Stimulation for Axial Dysfunction in Parkinson's Disease: A Randomized TrialJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1079End Page: 1087Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28953Citation Count: 17
- Physician‐Assisted Dying: Access and Utilization in Patients with Movement Disorders2022RESTRICTEDTitle: Physician‐Assisted Dying: Access and Utilization in Patients with Movement DisordersJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 694End Page: 698Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28964Citation Count: 4
- The Role of Insular Cortex in Gut‐Inflammation Memory: What Does It Mean for Parkinson's Disease?2022RESTRICTEDTitle: The Role of Insular Cortex in Gut‐Inflammation Memory: What Does It Mean for Parkinson's Disease?Journal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 4Start Page: 700End Page: 701Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28975Citation Count: 2
- Abstracts2022RESTRICTEDTitle: AbstractsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: S1Start Page: S1End Page: S36Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29002Citation Count: 0
- Implementation and Outcomes of a Movement Disorder Society‐Sponsored Peer Reviewing Education and Mentoring Program2022RESTRICTEDTitle: Implementation and Outcomes of a Movement Disorder Society‐Sponsored Peer Reviewing Education and Mentoring ProgramJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 1093End Page: 1097Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28978Citation Count: 3
-
OPENTitle: Parkin Deficiency Impairs Mitochondrial DNA Dynamics and Propagates InflammationJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1405End Page: 1415Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29025Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29025Citation Count: 76
- Assessment of GGC Repeat Expansion in GIPC1 in Patients with Parkinson's Disease2022RESTRICTEDTitle: Assessment of GGC Repeat Expansion in GIPC1 in Patients with Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1557End Page: 1559Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29041Citation Count: 14
- Exposure to Pesticides Predicts Prodromal Feature of Parkinson's Disease: Public Health Implications2022OPENTitle: Exposure to Pesticides Predicts Prodromal Feature of Parkinson's Disease: Public Health ImplicationsJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 5Start Page: 883End Page: 885Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.29012Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29012Citation Count: 6
- TDP‐43 Proteinopathy Presenting with Typical Symptoms of Parkinson's Disease2022RESTRICTEDTitle: TDP‐43 Proteinopathy Presenting with Typical Symptoms of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 7Start Page: 1561End Page: 1563Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.29048Citation Count: 36
- A New Approach to the Development of Disease‐Modifying Therapies for PD2021RESTRICTEDTitle: A New Approach to the Development of Disease‐Modifying Therapies for PDJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1281End Page: 1281Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28589Citation Count: 1
-
OPENTitle: Corneal Confocal Microscopy Identifies Parkinson's Disease with More Rapid Motor ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1927End Page: 1934Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1002/mds.28602Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28602Citation Count: 30
- Cerebrospinal α‐Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal Cohort2021OPENTitle: Cerebrospinal α‐Synuclein Oligomers Reflect Disease Motor Severity in DeNoPa Longitudinal CohortJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 9Start Page: 2048End Page: 2056Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28611Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28611Citation Count: 43
- Reply to: “A New Approach to the Development of Disease‐Modifying Therapies for PD”2021RESTRICTEDTitle: Reply to: “A New Approach to the Development of Disease‐Modifying Therapies for PD”Journal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 5Start Page: 1281End Page: 1282Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28588Citation Count: 0